Total Funding
29
Total FundingSeries A raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
561973
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.
Matthew R. Ritter: Manager, Research and Development
About the Company
EyeCyte, Inc. is working with Pfizer's Bioinnovation and io therapeutics Center and The Scripps Research Institute to develop novel therapeutics to treat neovascular and degenerative retinal disease.
